10X GENOMICS INC-CLASS A (TXG)

Shhh! 3 Secret Nanotech Stocks Flying Below Wall Street’s Radar

You might want to get in on these three under-the-radar nanotech stocks before Wall Street catches on to the technology's potential.

Cathie Wood’s Latest Buys: 3 Stocks the ARK Invest CEO Can’t Get Enough Of

Cathie Wood stock picks focus on the big ideas she has on where the future will be. Sometimes it means her picks will be down more for longer.

First Week of TXG July 19th Options Trading

10x Genomics to Present at the BofA Securities 2024 Healthcare Conference

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will...

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire

Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.

These stocks are moving in today's pre-market session

Get insights into the top gainers and losers of Wednesday's pre-market session.

TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024

TXG stock results show that 10x Genomics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

TXG Stock Earnings: 10x Genomics Meets EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips 10x Genomics (NASDAQ:TXG) just reported results for the first quarter of 2024.1...

10x Genomics Reports First Quarter 2024 Financial Results

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended...

First Week of TXG June 21st Options Trading

10x Genomics is Now Oversold (TXG)

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the...

10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD...

10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Xenium...

10x Genomics is Now Oversold (TXG)

10x Genomics Begins Commercial Shipments of Chromium GEM-X Products

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping the first two...

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.

10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will...

10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full...

3 Gene Editing Stocks With Unprecedented Surge Potential

While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.

Why Is NanoString (NSTG) Stock Up 115% Today?

Although NanoString fell under severe pressure due to its bankruptcy filing, a credit agreement breathed new life into NSTG stock.

Bullish Two Hundred Day Moving Average Cross - TXG

10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of GEM-X, the next generation of the...

10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology...